Press Releases

April 5, 2021 | Network News, Press Releases

John Theurer Cancer Center Investigators Celebrate Newly Approved Lymphoma Therapies Evaluated in Clinical Trials at...

New Treatments Expand Options for Patients with Persistent Cancers

The U.S. Food and Drug Administration recently approved two new treatment approaches for certain types of non-Hodgkin lymphomas which were assessed in pioneering clinical trials at John Theurer Cancer Center at Hackensack Meridian Hackensack University Medical Center: umbralisib and CAR T-cell therapy.